These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27423423)

  • 61. Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population.
    Adonis MI; Díaz J; Miranda VR; Chahuan M; Zambrano A; Benitez HC; Campos M; Avaria P; Urzúa U; Marín P; Gohurdett M; Cisterna Y; Gil L
    Biol Res; 2014 Nov; 47(1):62. PubMed ID: 25723567
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
    Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
    Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Colorectal cancer detection using targeted serum metabolic profiling.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
    J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer.
    Jung YJ; Oh IJ; Kim Y; Jung JH; Seok M; Lee W; Park CK; Lim JH; Kim YC; Kim WS; Choi CM
    J Korean Med Sci; 2018 Dec; 33(53):e342. PubMed ID: 30595683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
    Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
    J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.
    Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
    J Breath Res; 2016 Mar; 10(2):026002. PubMed ID: 27007686
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
    Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
    J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
    Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis.
    Uribarri M; Hormaeche I; Zalacain R; Lopez-Vivanco G; Martinez A; Nagore D; Ruiz-Argüello MB
    J Thorac Oncol; 2014 Oct; 9(10):1504-12. PubMed ID: 25105437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y; Song X; Zhao X; Zou L; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
    Sahiner I; Atasever T; Akdemir UO; Ozturk C; Memis L
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):357-63. PubMed ID: 23747221
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
    Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
    Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolomics-based search for lung cancer markers among patients with different smoking status.
    Klupczynska-Gabryszak A; Daskalaki E; Wheelock CE; Kasprzyk M; Dyszkiewicz W; Grabicki M; Brajer-Luftmann B; Pawlak M; Kokot ZJ; Matysiak J
    Sci Rep; 2024 Jul; 14(1):15444. PubMed ID: 38965272
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry.
    Xiao H; Zhang L; Zhou H; Lee JM; Garon EB; Wong DT
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.012112. PubMed ID: 22096114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.